List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 922 studies with search of: Myelodysplastic Syndromes
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Phase I Trial of Vorinostat (MK0683, SAHA) in Combination With Decitabine in Patients With AML or MDS.
Conditions: Leukemia, Myelocytic, Acute Myelodysplastic Syndromes;   Myelodysplastic Syndromes
Interventions: Drug: Comparator: vorinostat (sequential);   Drug: Comparator: decitabine;   Drug: Comparator: vorinostat (concurrent)
2 Not yet recruiting Sodium Stibogluconate in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: sodium stibogluconate
3 Terminated Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
Conditions: Myelodysplastic Syndromes;   Leukemia, Myelomonocytic, Chronic;   Myelodysplasia;   Myelomonocytic
Interventions: Drug: Lonafarnib;   Other: Placebo
4 Not yet recruiting Studying Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Hematopoietic/Lymphoid Cancer;   Accelerated Phase Chronic Myelogenous Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Childhood Chronic Myelogenous Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Recurrent Adult Acute Lymphoblastic Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Adult Acute Myeloid Leukemia in Remission;   Recurrent Adult Acute Myeloid Leukemia;   Childhood Acute Myeloid Leukemia in Remission;   Recurrent Childhood Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Disease, Unclassifiable;   Childhood Myelodysplastic Syndromes;   de Novo Myelodysplastic Syndromes;   Secondary Myelodysplastic Syndromes;   HIV-associated Hodgkin Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Burkitt Lymphoma;   HIV Infections
Interventions: Procedure: leukapheresis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis;   Other: DNA analysis;   Other: RNA analysis;   Other: flow cytometry;   Other: reverse transcriptase-polymerase chain reaction;   Other: nucleic acid sequencing;   Other: protein expression analysis
5 Recruiting Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
Conditions: Advanced Myelodysplastic Syndrome;   Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia After MDS;   Thrombocytopenia
Interventions: Drug: eltrombopag olamine;   Other: Placebo
6 Active, not recruiting Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: arsenic trioxide
7 Active, not recruiting Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: azacitidine
8 Suspended Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclosporine;   Drug: methotrexate;   Drug: methoxsalen;   Drug: mycophenolate mofetil;   Drug: pentostatin;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
9 Completed Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: carboplatin;   Drug: fludarabine phosphate;   Drug: thalidomide;   Drug: topotecan hydrochloride
10 Active, not recruiting Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: azacitidine
11 Recruiting Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine;   Drug: tretinoin;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: microarray analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunohistochemistry staining method
12 Recruiting Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: thioguanine
13 Not yet recruiting Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: lintuzumab;   Drug: azacitidine;   Other: pharmacological study
14 Recruiting Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Biological: GM-K562 cell vaccine;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
15 Active, not recruiting Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Dietary Supplement: cholecalciferol;   Drug: arsenic trioxide
16 Not yet recruiting Everolimus in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: everolimus;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
17 Recruiting PXD101 in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: belinostat
18 Active, not recruiting Paricalcitol in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: paricalcitol
19 Completed Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: decitabine
20 Completed Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: decitabine;   Drug: romidepsin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services